Disclosed the October 2026 monthly exercise status of the 25th stock acquisition rights issued in December 2025. Of 113,100 shares granted, 1,131 units were exercised, representing an exercise ratio of 1.31%. Unexercised units at month-end were 36,135 shares, compared with 37,266 shares at the end of the previous month. Exercise dates include October 9 and October 21.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7776","jir_company_name":"CellSeed Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-02","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/7776-20261102-01.pdf","jir_short_summary":"Disclosed the October 2026 monthly exercise status of the 25th stock acquisition rights issued in December 2025. Of 113,100 shares granted, 1,131 units were exercised, representing an exercise ratio of 1.31%. Unexercised units at month-end were 36,135 shares, compared with 37,266 shares at the end of the previous month. Exercise dates include October 9 and October 21.","jir_summary":"### Monthly Disclosure of Stock Acquisition Rights Exercise Status\nCellSeed Inc. has disclosed the monthly exercise status of the 25th stock acquisition rights (with an exercise price adjustment clause). For the subject month, the number of shares granted was 113,100 shares, of which 1,131 units were actually exercised and converted into new shares. The exercise ratio against the total issued was 1.31%, and unexercised shares at month-end totaled 36,135 shares. Exercise dates primarily included multiple days such as October 9 and October 21. The number of unexercised shares decreased from 37,266 shares at the end of the previous month.\n\n### Impact and Background\nThis month's exercises were relatively small in scale, and the overall exercise ratio remained low. The number of unexercised shares continues at a certain level, and dilution may vary depending on future exercise trends. References were made to previously disclosed information such as third-party allotments, and the application status of issuance conditions and exercise provisions is a point of attention.","jir_financial_highlights":"Granted shares: 113,100 shares (Unknown)\nNumber of stock acquisition rights exercised: 1,131 units (Unknown)\nTotal number of stock acquisition rights issued: 86,000 units (Unknown)\nExercise ratio: 1.31% (Unknown)\nUnexercised stock acquisition rights at end of previous month: 37,266 units (Unknown)\nUnexercised stock acquisition rights at month-end: 36,135 units (Unknown)\nExercise restriction rate: 0.32% (Unknown)","jir_category":"","jir_hashtags":"#CellSeed, #StockAcquisitionRights, #StockOptionExerciseStatus","jir_key_figures":"Granted shares: 113,100 shares\nNumber of stock acquisition rights exercised: 1,131 units\nTotal number of stock acquisition rights issued: 86,000 units","jir_meta_title":"CellSeed Inc. Announces Monthly Exercise Status of Stock Acquisition Rights | October 2026","jir_meta_description":"CellSeed Inc. disclosed the October 2026 monthly exercise status of the 25th stock acquisition rights. Of 113,100 shares granted, 1,131 units were exercised (exercise ratio 1.31%), and 36,135 shares remained unexercised.","jir_og_title":"CellSeed Inc.: Monthly Exercise Status of Stock Acquisition Rights Announced | October 2026","jir_og_description":"CellSeed Inc. announced the monthly exercise status of stock acquisition rights: 1,131 units exercised, 36,135 units unexercised, exercise ratio 1.31%.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59075,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-140367","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n